Drugs / H5-VLP
last change Jan 2014 re-read 2 minutes ago

H5-VLP

Vaccine

Developed for
avian influenza
Investigated by
Access to Advanced Health Institute (AAHI) · Defense Advanced Research Projects Agency · Medicago

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01657929 Sep 2012 → Jan 2014 avian influenza Access to Advanced Health Institute (AAHI) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as H5-VLP ClinicalTrials.gov intervention name — accepted as the source's own label NCT01657929
Modality Vaccine “investigational vaccine being developed for the prevention of pandemic influenza” NCT01657929